Enhancement of proteasome function by PA28α overexpression protects against oxidative stress

FASEB Journal

Volumn 25, Issue 3, 2011, Pages 883-893

  Li, Jie ^a   Powell, Saul R ^b   Wang, Xuejun ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Apoptosis; Cell culture; Green fluorescence protein; Oxidized proteins; Proteasome activator 28

Indexed keywords

CARBONYL DERIVATIVE; HYDROGEN PEROXIDE; PROTEASOME; PROTEASOME ACTIVATOR 11S; PROTEASOME ACTIVATOR 28; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; APOPTOSIS; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; MICE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; RABBITS; RATS;

RATTUS;

EID: 79954590790     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-160895     Document Type: Article

References (61)

1. Wang, X., and Robbins, J. (2006) Heart failure and protein quality control. Circ. Res. 99, 1315-1328 (Pubitemid 44949667)
2. Patterson, C., Ike, C., Willis, P. W., Stouffer, G. A., and Willis, M. S. (2007) The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation 115, 1456-1463 (Pubitemid 46648383)
3. Young, G. W., Wang, Y., and Ping, P. (2008) Understanding proteasome assembly and regulation: importance to cardiovascular medicine. Trends Cardiovasc. Med. 18, 93-98 (Pubitemid 351626605)
4. Mearini, G., Schlossarek, S., Willis, M. S., and Carrier, L. (2008) The ubiquitin-proteasome system in cardiac dysfunction. Biochim. Biophys. Acta 1782, 749-763
5. Wang, X., Su, H., and Ranek, M. J. (2008) Protein quality control and degradation in cardiomyocytes. J. Mol. Cell. Cardiol. 45, 11-27
6. Powell, S. R. (2006) The ubiquitin-proteasome system in cardiac physiology and pathology. Am. J. Physiol. Heart Circ. Physiol. 291, H1-H19
7. Tanahashi, N., Murakami, Y., Minami, Y., Shimbara, N., Hendil, K. B., and Tanaka, K. (2000) Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J. Biol. Chem. 275, 14336-14345 (Pubitemid 30339716)
8. Cascio, P., Call, M., Petre, B. M., Walz, T., and Goldberg, A. L. (2002) Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J. 21, 2636-2645 (Pubitemid 34619379)
9. Husom, A. D., Peters, E. A., Kolling, E. A., Fugere, N. A., Thompson, L. V., and Ferrington, D. A. (2004) Altered proteasome function and subunit composition in aged muscle. Arch. Biochem. Biophys. 421, 67-76 (Pubitemid 37543497)
10. Powell, S. R., Samuel, S. M., Wang, P., Divald, A., Thirunavukkarasu, M., Koneru, S., Wang, X., and Maulik, N. (2008) Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia. J. Mol. Cell. Cardiol. 44, 618-621
11. Gomes, A. V., Zong, C., Edmondson, R. D., Li, X., Stefani, E., Zhang, J., Jones, R. C., Thyparambil, S., Wang, G. W., Qiao, X., Bardag-Gorce, F., and Ping, P. (2006) Mapping the murine cardiac 26S proteasome complexes. Circ. Res. 99, 362-371 (Pubitemid 44253692)
12. Realini, C., Jensen, C. C., Zhang, Z., Johnston, S. C., Knowlton, J. R., Hill, C. P., and Rechsteiner, M. (1997) Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J. Biol. Chem. 272, 25483-25492 (Pubitemid 27438854)
13. Zhang, Z., Krutchinsky, A., Endicott, S., Realini, C., Rechsteiner, M., and Standing, K. G. (1999) Proteasome activator 11S REG or PA28: recombinant REG alpha/REG beta hetero-oligomers are heptamers. Biochemistry 38, 5651-5658
14. Chen, X., Barton, L. F., Chi, Y., Clurman, B. E., and Roberts, J. M. (2007) Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol. Cell 26, 843-852 (Pubitemid 46921008)
15. Murata, S., Udono, H., Tanahashi, N., Hamada, N., Watanabe, K., Adachi, K., Yamano, T., Yui, K., Kobayashi, N., Kasahara, M., Tanaka, K., and Chiba, T. (2001) Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. EMBO J. 20, 5898-5907 (Pubitemid 33049265)
16. Stohwasser, R., Salzmann, U., Giesebrecht, J., Kloetzel, P. M., and Holzhutter, H. G. (2000) Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28. FEBS J. 267, 6221-6230
17. Whitby, F. G., Masters, E. I., Kramer, L., Knowlton, J. R., Yao, Y., Wang, C. C., and Hill, C. P. (2000) Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 408, 115-120
18. Groettrup, M., Soza, A., Eggers, M., Kuehn, L., Dick, T. P., Schild, H., Rammensee, H. G., Koszinowski, U. H., and Kloetzel, P. M. (1996) A role for the proteasome regulator PA28alpha in antigen presentation. Nature 381, 166-168
19. Kloetzel, P. M., Soza, A., and Stohwasser, R. (1999) The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response. Biol. Chem. 380, 293-297 (Pubitemid 29145942)
20. Murata, S., Kawahara, H., Tohma, S., Yamamoto, K., Kasahara, M., Nabeshima, Y., Tanaka, K., and Chiba, T. (1999) Growth retardation in mice lacking the proteasome activator PA28gamma. J. Biol. Chem. 274, 38211-38215 (Pubitemid 30026896)
21. Ferrington, D. A., Husom, A. D., and Thompson, L. V. (2005) Altered proteasome structure, function, and oxidation in aged muscle. FASEB J. 19, 644-646 (Pubitemid 40471272)
22. Barton, L. F., Runnels, H. A., Schell, T. D., Cho, Y., Gibbons, R., Tevethia, S. S., Deepe, G. S., Jr., and Monaco, J. J. (2004) Immune defects in 28-kDa proteasome activator gamma-deficient mice. J. Immunol. 172, 3948-3954 (Pubitemid 38337983)
23. Li, X., Lonard, D. M., Jung, S. Y., Malovannaya, A., Feng, Q., Qin, J., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. (2006) The SRC-3/AIB1 coactivator is degraded in a ubiquitin-and ATP-independent manner by the REGgamma proteasome. Cell 124, 381-392 (Pubitemid 43121985)
24. Li, X., Amazit, L., Long, W., Lonard, D. M., Monaco, J. J., and O'Malley, B. W. (2007) Ubiquitin-and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol. Cell 26, 831-842 (Pubitemid 46921009)
25. Kumarapeli, A. R., Horak, K. M., Glasford, J. W., Li, J., Chen, Q., Liu, J., Zheng, H., and Wang, X. (2005) A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin. FASEB J. 19, 2051-2053 (Pubitemid 41759762)
26. Bence, N. F., Sampat, R. M., and Kopito, R. R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555 (Pubitemid 32493425)
27. Gilon, T., Chomsky, O., and Kulka, R. G. (2000) Degradation signals recognized by the Ubc6p-Ubc7p ubiquitin-conjugating enzyme pair. Mol. Cell. Biol. 20, 7214-7219
28. Chen, Q., Liu, J. B., Horak, K. M., Zheng, H., Kumarapeli, A. R., Li, J., Li, F., Gerdes, A. M., Wawrousek, E. F., and Wang, X. (2005) Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ. Res. 97, 1018-1026 (Pubitemid 41668915)
29. Sarikas, A., Carrier, L., Schenke, C., Doll, D., Flavigny, J., Lindenberg, K. S., Eschenhagen, T., and Zolk, O. (2005) Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc. Res. 66, 33-44 (Pubitemid 40357866)
30. Weekes, J., Morrison, K., Mullen, A., Wait, R., Barton, P., and Dunn, M. J. (2003) Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 3, 208-216 (Pubitemid 36254603)
31. Herrmann, J., Saguner, A. M., Versari, D., Peterson, T. E., Chade, A., Olson, M., Lerman, L. O., and Lerman, A. (2007) Chronic proteasome inhibition contributes to coronary atherosclerosis. Circ. Res. 101, 865-874 (Pubitemid 350287173)
32. Predmore, J. M., Wang, P., Davis, F., Bartolone, S., Westfall, M. V., Dyke, D. B., Pagani, F., Powell, S. R., and Day, S. M. (2010) Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 121, 997-1004
33. Divald, A., Kivity, S., Wang, P., Hochhauser, E., Roberts, B., Teichberg, S., Gomes, A. V., and Powell, S. R. (2010) Myocardial ischemic preconditioning preserves postischemic function of the 26S proteasome through diminished oxidative damage to 19S regulatory particle subunits. Circ. Res. 106, 1829-1838
34. Tang, M., Li, J., Huang, W., Su, H., Liang, Q., Tian, Z., Horak, K. M., Molkentin, J. D., and Wang, X. (2010) Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. Cardiovasc. Res. 88, 424-433
35. Dong, X., Liu, J., Zheng, H., Glasford, J. W., Huang, W., Chen, Q. H., Harden, N. R., Li, F., Gerdes, A. M., and Wang, X. (2004) In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 287, H1417-H1425 (Pubitemid 39096692)
36. Schwartzbauer, G., and Robbins, J. (2001) The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J. Biol. Chem. 276, 35786-35793
37. Su, H., Huang, W., and Wang, X. (2009) The COP9 signalosome negatively regulates proteasome proteolytic function and is essential to transcription. Int. J. Biochem. Cell Biol. 41, 615-624
38. Powell, S. R., Davies, K. J., and Divald, A. (2007) Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations. J. Mol. Cell. Cardiol. 42, 265-269 (Pubitemid 44970471)
39. Huang, H., Zhang, X., Li, S., Liu, N., Lian, W., McDowell, E., Zhou, P., Zhao, C., Guo, H., Zhang, C., Yang, C., Wen, G., Dong, X., Lu, L., Ma, N., Dong, W., Dou, Q. P., Wang, X., and Liu, J. (2010) Physiological levels of ATP negatively regulate proteasome function. [E-pub ahead of print] Cell Res. doi:038/cr.2010.123
40. Liu, J., Chen, Q., Huang, W., Horak, K. M., Zheng, H., Mestril, R., and Wang, X. (2006) Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J. 20, 362-364 (Pubitemid 46671172)
41. Liu, J., Tang, M., Mestril, R., and Wang, X. (2006) Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J. Mol. Cell. Cardiol. 40, 451-454
42. Su, H., and Wang, X. (2010) The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Cardiovasc. Res. 85, 253-262
43. Cascio, P., and Goldberg, A. L. (2005) Preparation of hybrid (19S-20S-PA28) proteasome complexes and analysis of peptides generated during protein degradation. Methods Enzymol. 398, 336-352 (Pubitemid 41578896)
44. Gomes, A. V., Young, G. W., Wang, Y., Zong, C., Eghbali, M., Drews, O., Lu, H., Stefani, E., and Ping, P. (2009) Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues. Mol. Cell. Proteomics 8, 302-315
45. Zong, C., Gomes, A. V., Drews, O., Li, X., Young, G. W., Berhane, B., Qiao, X., French, S. W., Bardag-Gorce, F., and Ping, P. (2006) Regulation of murine cardiac 20S proteasomes: role of associating partners. Circ. Res. 99, 372-380 (Pubitemid 44253693)
46. Drews, O., Wildgruber, R., Zong, C., Sukop, U., Nissum, M., Weber, G., Gomes, A. V., and Ping, P. (2007) Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol. Cell. Proteomics 6, 2021-2031 (Pubitemid 350201875)
47. Lu, H., Zong, C., Wang, Y., Young, G. W., Deng, N., Souda, P., Li, X., Whitelegge, J., Drews, O., Yang, P. Y., and Ping, P. (2008) Revealing the dynamics of 20S proteasome phosphoproteome: A combined CID and ETD approach. Mol. Cell. Proteomics 7, 2073-2089
48. Kloss, A., Meiners, S., Ludwig, A., and Dahlmann, B. (2010) Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors. Cardiovasc. Res. 85, 367-375
49. Song, X., Mott, J. D., von Kampen, J., Pramanik, B., Tanaka, K., Slaughter, C. A., and DeMartino, G. N. (1996) A model for the quaternary structure of the proteasome activator PA28. J. Biol. Chem. 271, 26410-26417 (Pubitemid 26347999)
50. Preckel, T., Fung-Leung, W. P., Cai, Z., Vitiello, A., Salter-Cid, L., Winqvist, O., Wolfe, T. G., Von Herrath, M., Angulo, A., Ghazal, P., Lee, J. D., Fourie, A. M., Wu, Y., Pang, J., Ngo, K., Peterson, P. A., Fruh, K., and Yang, Y (1999) Impaired immunoproteasome assembly and immune responses in PA28-/-mice. Science 286, 2162-2165 (Pubitemid 129516292)
51. Ravid, T., and Hochstrasser, M. (2008) Diversity of degradation signals in the ubiquitin-proteasome system. Nat. Rev. Mol. Cell. Biol. 9, 679-690
52. Salomons, F. A., Menendez-Benito, V., Bottcher, C, McCray, B. A., Taylor, J. P., and Dantuma, N. P. (2009) Selective accumulation of aggregation-prone proteasome substrates in response to proteotoxic stress. Mol. Cell. Biol. 29, 1774-1785
53. Whittier, J. E., Xiong, Y, Rechsteiner, M. C, and Squier, T. C. (2004) Hsp90 enhances degradation of oxidized calmodulin by the 20 S proteasome. J. Biol. Chem. 279, 46135-46142 (Pubitemid 39491608)
54. Imai, J., Maruya, M., Yashiroda, H., Yahara, I., and Tanaka, K (2003) The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome. EMBOJ. 22, 3557-3567 (Pubitemid 36898333)
55. Yamano, T., Murata, S., Shimbara, N., Tanaka, N., Chiba, T., Tanaka, K., Yui, K., and Udono, H. (2002) Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing. J. Exp. Med. 196, 185-196 (Pubitemid 34787508)
56. Minami, Y., Kawasaki, H., Minami, M., Tanahashi, N., Tanaka, K., and Yahara, I. (2000) A critical role for the proteasome activator PA28 in the Hsp90-dependent protein refolding. J. Biol. Chem. 275, 9055-9061 (Pubitemid 30180266)
57. Lu, X., Michaud, C, and Orlowski, M. (2001) Heat shock protein-90 and the catalytic activities of the 20 S proteasome (multicatalytic proteinase complex). Arch. Biochem. Biophys. 387, 163-171 (Pubitemid 32989036)
58. Bahrudin, U., Morisaki, H., Morisaki, T., Ninomiya, H., Higaki, K., Nanba, E., Igawa, O., Takashima, S., Mizuta, E., Miake, J., Yamamoto, Y, Shirayoshi, Y, Kitakaze, M., Carrier, L., and Hisatome, I. (2008) Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. J. Mol. Biol. 384, 896-907
59. Tannous, P., Zhu, H., Nemchenko, A., Berry, J. M., Johnstone, J. L., Shelton, J. M., Miller, F. J., Jr., Rothermel, B. A., and Hill, J. A. (2008) Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation 117, 3070-3078
60. Sanbe, A., Osinska, H., Saffitz, J. E., Glabe, C. G., Kayed, R., Maloyan, A., and Robbins, J. (2004) Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc. Natl. Acad. Sci. U. S. A. 101, 10132-10136 (Pubitemid 38891207)
61. Chen, J., and Liu, X. (2009) The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications. Cell. Immunol. 254, 85-90